Table 4.

Comparing induction therapy between PTDM and non-PTDM groupsa

Induction TherapyaNo Post-transplant Diabetes Mellitus, n (%)Post-transplant Diabetes Mellitus, n (%)
Pretransplant desensitization protocol used29 (7)6 (3)
Intravenous immunoglobulin39 (9)11 (6)
Methylprednisolone407 (91)177 (95)
Anti-thymocyte globulin (rabbit)368 (83)157 (84)
Basiliximab64 (14)31 (17)
Alemtuzumab15 (3)3 (2)
Rituximab9 (2)1 (1)
Experimental or other drug used for induction7 (2)2 (1)
  • a Induction immunosuppression was not significantly different between recipients with and without post-transplant diabetes mellitus (P>0.05).